Detalhe da pesquisa
1.
Validating the Baveno Elastography Criteria of Advanced Liver Fibrosis in Two-dimensional Shear Wave Elastography: A Prospective Pathology-based Study.
Dig Dis
; 2024 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38697048
2.
Risk Stratification for Hepatitis B Virus Reactivation in Kidney Transplant Recipients With Resolved HBV Infection.
Transpl Int
; 36: 11122, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37125384
3.
Grazoprevir/Elbasvir Treatment in Liver or Kidney Transplant Recipients with Genotype 1b Hepatitis C Virus Infection.
Antimicrob Agents Chemother
; 66(2): e0200321, 2022 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34902265
4.
Advances in the Era of Direct-Acting Antivirals for Hepatitis C in Patients with Unresectable Hepatocellular Carcinoma.
Dig Dis
; 40(5): 616-624, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34753149
5.
Clinical Profiles of Asians with NAFLD: A Systematic Review and Meta-Analysis.
Dig Dis
; 40(6): 734-744, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34942625
6.
Establishing the blood reference interval of pancreatic elastase-1: A prospective study.
J Gastroenterol Hepatol
; 37(1): 117-123, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34498301
7.
Accuracy of simultaneous measurement of serum biomarkers: Carbohydrate antigen 19-9, pancreatic elastase-1, amylase, and lipase for diagnosing pancreatic ductal adenocarcinoma.
J Formos Med Assoc
; 121(12): 2601-2607, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35918272
8.
Evaluating the renal safety of tenofovir disoproxil fumarate in hepatitis B patients without chronic kidney disease.
J Viral Hepat
; 28(11): 1579-1586, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34464999
9.
Association of Daily Aspirin Therapy With Hepatocellular Carcinoma Risk in Patients With Chronic Hepatitis C Virus Infection.
Clin Gastroenterol Hepatol
; 18(12): 2784-2792.e7, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32360983
10.
Development of a scoring system to predict hepatocellular carcinoma in Asians on antivirals for chronic hepatitis B.
J Hepatol
; 69(2): 278-285, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29551708
11.
Effect of Nucleos(t)ide Analogue Therapy on Risk of Intrahepatic Cholangiocarcinoma in Patients With Chronic Hepatitis B.
Clin Gastroenterol Hepatol
; 16(6): 947-954.e4, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28951229
12.
Temporal trend and risk determinants of hepatocellular carcinoma in chronic hepatitis B patients on entecavir or tenofovir.
J Viral Hepat
; 25(5): 543-551, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29193536
13.
Risk factors and metabolic abnormality of patients with non-alcoholic fatty liver disease: Either non-obese or obese Chinese population.
Hepatobiliary Pancreat Dis Int
; 17(1): 45-48, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-29428103
14.
The occurrence of hepatocellular carcinoma in different risk stratifications of clinically noncirrhotic nonalcoholic fatty liver disease.
Int J Cancer
; 141(7): 1307-1314, 2017 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28509327
15.
Association between nucleos(t)ide analog and tumor recurrence in hepatitis B virus-related hepatocellular carcinoma after radiofrequency ablation.
Hepatology
; 63(5): 1517-27, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26426978
16.
The association of non-alcoholic fatty liver disease and metabolic syndrome in a Chinese population.
Hepatobiliary Pancreat Dis Int
; 16(2): 176-180, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28381382
17.
Association between ultrasonography screening and mortality in patients with hepatocellular carcinoma: a nationwide cohort study.
Gut
; 65(4): 693-701, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25670811
18.
Reply.
Clin Gastroenterol Hepatol
; 19(7): 1512, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34147237
19.
The Incidence of Gastric Adenocarcinoma Among Patients With Gastric Intestinal Metaplasia: A Long-term Cohort Study.
J Clin Gastroenterol
; 50(7): 532-7, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-26444645
20.
Association between proton pump inhibitor use and mortality in patients with hepatocellular carcinoma receiving tyrosine kinase inhibitor.
Gut
; 2020 Sep 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32907829